Proveris Scientific, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced that it has been acquired by an independent subsidiary of Investindustrial, a leading European group of independently managed investment, holding, and advisory companies with a long history in the healthcare sector. Following the transaction, the company will continue to operate as an independent company.

Founded in 1990 and rooted in an industrialist family heritage, Investindustrial has 35 years of history supporting the sustainable development of leading mid-market companies on a global basis. Proveris and its founder, Dino Farina, have chosen to partner with Investindustrial to support the next phase of development after ample consideration due to the group’s extensive track record, relevant expertise in the healthcare sector, long term orientation, and shared commitment to strong corporate values.

“The partnership with InvestIndustrial provides us with additional resources and capabilities to drive growth and support our customers success over the long term,” said Dino Farina, CEO. “This includes investment in people, capabilities, and infrastructure, as well as the ability to pursue partnerships and acquisitions that strengthen our offering.”

For customers, Investindustrial’s investment in Proveris is expected to strengthen the company’s positioning, support continued innovation, and enhance its ability to effectively serve customers globally. With the backing of a new industrially-oriented, long-term shareholder, and building on a strong foundation and history of driving innovation at Proveris, the Company is positioned to further expand its capabilities and continue to support efficient drug development across both small and large molecule programs.

“Our focus remains the same — supporting customers with high-quality science and reliable data — now with the additional resources of a committed long-term partner to guide the next phase of business development,” said Chip Leveille, President.

About Proveris Scientific

Proveris Scientific advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, laboratory services, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris Scientific’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.